Canada Hyaluronic Acid Market Size & Outlook, 2026-2033
Related Markets
Canada hyaluronic acid market highlights
- The Canada hyaluronic acid market generated a revenue of USD 356.7 million in 2025 and is expected to reach USD 642.1 million by 2033.
- The Canada market is expected to grow at a CAGR of 7.6% from 2026 to 2033.
- In terms of segment, dermal fillers was the largest revenue generating application in 2025.
- Dermal Fillers is the most lucrative application segment registering the fastest growth during the forecast period.
Hyaluronic acid market data book summary
| Market revenue in 2025 | USD 356.7 million |
| Market revenue in 2033 | USD 642.1 million |
| Growth rate | 7.6% (CAGR from 2026 to 2033) |
| Largest segment | Dermal fillers |
| Fastest growing segment | Dermal Fillers |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dermal Fillers, Vesicoureteral Reflux, Osteoarthritis, Ophthalmic |
| Key market players worldwide | Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology |
Other key industry trends
- In terms of revenue, Canada accounted for 3.1% of the global hyaluronic acid market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. hyaluronic acid market is projected to lead the regional market in terms of revenue in 2033.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 240.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hyaluronic Acid Market Scope
Hyaluronic Acid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| HTL Biotechnology | View profile | - | Javené, Bretagne, France, Europe | http://www.htl-bio.com |
| Genzyme | View profile | 10001+ | Cambridge, Massachusetts, United States, North America | http://www.genzyme.com |
| Seikagaku | View profile | 501-1000 | Marunouchi, Tokyo, Japan, Asia | https://www.seikagaku.co.jp/ |
| Maruha Nichiro Corp | View profile | 26222 | 3-20-20 Toyosu, Koto-ku, Toyosu Front, Tokyo, Japan | http://www.maruha-nichiro.co.jp |
| Bloomage BioTechnology | View profile | 501-1000 | Beijing, Beijing, China, Asia | http://www.bloomagebio-tech.com/e/index.php |
| Lifecore Biomedical Inc | View profile | 459 | 3515 Lyman Boulevard, Chaska, MN, United States, 55318 | https://www.lifecore.com |
| Bausch Health Companies Inc | View profile | 20270 | 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 | https://www.bauschhealth.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | https://www.ferring.com |
| Anika Therapeutics Inc | View profile | 357 | 32 Wiggins Avenue, Bedford, MA, United States, 01730 | https://www.anika.com |
| LG Chem | View profile | 10001+ | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | https://www.lgchem.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
| Allergan | View profile | 10001+ | Madison, Wisconsin, United States, North America | http://www.allergan.com |
| Shiseido Co Ltd | View profile | 35859 | 5-5 Ginza 7-chome, Chuo-ku, Tokyo, Japan, 104-0061 | http://www.shiseido.co.jp |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Nestle SA | View profile | 270000 | Avenue Nestle 55, Vevey, Switzerland, CH-1800 | https://www.nestle.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Canada hyaluronic acid market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hyaluronic acid market will help companies and investors design strategic landscapes.
Dermal fillers was the largest segment with a revenue share of 55.51% in 2025. Horizon Databook has segmented the Canada hyaluronic acid market based on dermal fillers, vesicoureteral reflux, osteoarthritis, ophthalmic covering the revenue growth of each sub-segment from 2021 to 2033.
Significant increase in the number of osteoarthritis cases and ophthalmic surgeries is propelling the demand for hyaluronic acid in Canada. According to Statistics Canada, osteoarthritis affects more than 10% of people aged 15 or older in Canada.
Furthermore, around 3.9 million people in Canada aged 20 & above were living with osteoarthritis, and 219,000 people were newly diagnosed during 2016-2017.
With age, the prevalence and incidence of diagnosed osteoarthritis increases, reaching 10.0 per 1,000 persons per year in women and 7.5 per 1,000 persons per year in men. This is an important factor fueling market growth in Canada.
Reasons to subscribe to Canada hyaluronic acid market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada hyaluronic acid market databook
-
Our clientele includes a mix of hyaluronic acid market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada hyaluronic acid market , including forecasts for subscribers. This country databook contains high-level insights into Canada hyaluronic acid market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Canada Application - Hyaluronic Acid Market size, 2025 - 2033 (US$M)
Canada Hyaluronic Acid Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
